Personalized Combination Therapy

Personalized Combination Therapy is a therapeutic strategy that belongs to the class of combination therapies and is distinguished by its systematic design and application of multiple repurposed drug regimens tailored to individual patient characteristics, such as genomic profiles, disease subtypes, and resistance mechanisms, to optimize efficacy and minimize adverse effects.

37

Publications

1.9K

Citations

353

Authors

163

Institutions

Publications per year

2017–2026

24

Authors

353

  1. MS
    Maria Schwaederlé

    University of California San Diego, United States

    2 publications · 731 citations

    2

    h-index

  2. TC
    Thorsten Cramer

    Charité - Universitätsmedizin Berlin, Germany

    2 publications · 113 citations

    2

    h-index

  3. MJ
    Mathew J. Garnett

    Wellcome Sanger Institute, United Kingdom

    2 publications · 113 citations

    2

    h-index

  4. FE
    Federica Eduati

    European Bioinformatics Institute, United Kingdom

    2 publications · 113 citations

    2

    h-index

  5. PJ
    Patricia Jaaks

    Wellcome Sanger Institute, United Kingdom

    2 publications · 113 citations

    2

    h-index

1–5 of 353

Venues

  1. BMC Cancer

    2 publications · 31 citations

    2

    h-index

  2. Nature Medicine

    2 publications · 738 citations

    2

    h-index

  3. Drug metabolism and drug interactions

    2 publications · 56 citations

    2

    h-index

  4. Molecular Systems Biology

    2 publications · 113 citations

    2

    h-index

  5. Journal of Clinical Oncology

    1 publications · 12 citations

    1

    h-index

1–5